Event Type
Disclosure
Voluntary
Variant
8-K
of this Current Report on Form 8-K, including the information set forth in Exhibits 99.1 and 99.2, is being furnished and shall not be deemed “filed” for purpos
Financial Statements and Exhibits (d) Exhibits Exhibit No. Document 99.1 Press Release of Sagimet Biosciences Inc., dated February 2, 2026. 99.2 Investor Presen